AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 472913
Drug: Oral PGE2
RxNorm normalized name: PGE2
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral PGE2 (5 mg total dose)
Trial: 472913
Drug: Intravaginal PGE2
RxNorm normalized name: PGE2
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravaginal PGE2 (4-6 mg in gel form)
Trial: 16461091
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg sildenafil 45 minutes before coitus for 2 months (Group 2)
Trial: 6992382
Drug: dimetikon 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: dimetikon 0.2 g 4 times daily, 3 days before examination
Trial: 24529619
Drug: Medication for
RxNorm normalized name: SALICYLIC ACID 10 mg in 1 mL TOPICAL LOTION [Serious Skincare Continuously Clear Acne Medication For Problematic skin Dry Lo Pro All- Over Treatment]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication for headache prophylaxis
Trial: 22759328
Drug: 10-day concomitant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10-day concomitant therapy (rabeprazole 20 mg twice daily, amoxicillin 1 g twice daily, metronidazole 400 mg three times a day, clarithromycin MR 1 g once daily)
Trial: 22759328
Drug: 5-day concomitant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-day concomitant therapy (rabeprazole 20 mg twice daily, amoxicillin 1 g twice daily, metronidazole 400 mg three times a day, clarithromycin MR 1 g once daily)
Trial: 7676685
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg acetylsalicylic acid (Thrombo-ASS 50 mg)
Trial: 7676685
Drug: Aspirin 100
RxNorm normalized name: aspirin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 100 mg (marketed preparation)
Trial: 2151741
Drug: Corticosteroids and/or
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroids and/or cytotoxic drugs
Trial: 15545305
Drug: Citalopram (dosage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram (dosage not specified)
Trial: 17534686
Drug: Bevacizumab (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bevacizumab (15 mg/kg intravenously every 2 weeks)
Trial: 17534686
Drug: Bevacizumab (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bevacizumab (15 mg/kg intravenously every 2 weeks) plus low-dose interferon alfa-2b (1 MU/m2 subcutaneously daily)
Trial: 17534686
Drug: Low-dose interferon
RxNorm normalized name: interferon-beta
DrugBank: Human interferon beta (DB14999)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose interferon alfa-2b (1 MU/m2 subcutaneously daily)
Trial: 17534686
Drug: Bevacizumab with
RxNorm normalized name: Bevacizumab
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Bevacizumab with or without low-dose interferon alfa-2b
Trial: 16701925
Drug: 3000 pfu
RxNorm normalized name: beremagene geperpavec
DrugBank: Beremagene geperpavec (DB17831)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3000 pfu Towne CMV vaccine with adjuvant recombinant interleukin-12 (rhIL-12)
Trial: 16701925
Drug: 3000 pfu
RxNorm normalized name: beremagene geperpavec
DrugBank: Beremagene geperpavec (DB17831)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3000 pfu Towne CMV vaccine without adjuvant recombinant interleukin-12 (rhIL-12)
Trial: 8795400
Drug: Pentosan polysulphate
RxNorm normalized name: Pentosan polysulphate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentosan polysulphate sodium (PPS) 200 mg three times daily for 6 weeks
Trial: 1825503
Drug: Captopril (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (25 mg t.i.d. for 5-6 weeks)
Trial: 31455871
Drug: scAT (subcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: scAT (subcutaneous abdominal adipose tissue)
Trial: 31827657
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of preoperative and postoperative PVB (Group C)
Trial: 23362336
Drug: No‐treatment control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No‐treatment control
Trial: 17934830
Drug: rabeprazole 10
RxNorm normalized name: RABEprazole 10 mg oral delayed release tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rabeprazole 10 mg
Trial: 24366288
Drug: omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: omeprazole 20 mg (CYP2C19 PM phenotype)
Trial: 24366288
Drug: rabeprazole 10
RxNorm normalized name: RABEprazole 10 mg oral delayed release tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rabeprazole 10 mg (CYP2C19 PM phenotype)
Trial: 15206909
Drug: Apomorphine 2
RxNorm normalized name: apomorphine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Apomorphine 2 mg (titrated up to 3 mg if necessary)
Trial: 15206909
Drug: Sildenafil 50
RxNorm normalized name: sildenafil 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil 50 mg (titrated up to 100 mg if necessary)
Trial: 11452249
Drug: Ibutamoren mesylate
RxNorm normalized name: Ibutamoren Mesylate
DrugBank: Ibutamoren (DB18214)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibutamoren mesylate 0.8 mg/kg per day for 8 days (group III)
Trial: 2839444
Drug: Post-operative thoracic
RxNorm normalized name: post oak pollen extract
DrugBank: Quercus stellata pollen (DB10888)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Post-operative thoracic radiation without systemic chemotherapy
Trial: 26353786
Drug: Collagen peptides
RxNorm normalized name: CASTOR OIL 100 g in 100 mL TOPICAL OIL [Anyi Beauty Biotin With Collagen Peptides Oil]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Collagen peptides (15 g/d)
Trial: 19549022
Drug: Decision support
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Decision support advising against nine potentially inappropriate medications
Trial: 17634049
Drug: Xian-zhong injection
RxNorm normalized name: Ma Chi Xian
DrugBank: Purslane (DB14327)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xian-zhong injection
Trial: 12583553
Drug: meropenem 500
RxNorm normalized name: meropenem 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: meropenem 500 mg i.v. t.i.d.
Trial: 31888713
Drug: Fluticasone nasal
RxNorm normalized name: fluticasone nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluticasone nasal spray and loratadine tablets
Trial: 21220074
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg oral hydrocortisone
Trial: 19371934
Drug: Amlodipine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine plus terazosin (5 mg Amlodipine + 2 mg terazosin)
Trial: 19371934
Drug: Terazosin (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terazosin (2 mg)
Trial: 17376205
Drug: Local heat
RxNorm normalized name: norethindrone
DrugBank: Norethisterone (DB00717)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Local heat therapy by radiofrequency (RF) at 50 degrees C for 30 s once weekly for 4 weeks
Trial: 17376205
Drug: Intralesional injection
RxNorm normalized name: DEXAMETHASONE SODIUM PHOSPHATE 4 mg in 1 mL INTRALESIONAL INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralesional injection of meglumine antimoniate once weekly for 4 weeks
Trial: 15456084
Drug: Reverset (RVT)
RxNorm normalized name: edrophonium chloride Injectable Solution [Reversol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reverset (RVT) 10 mg
Trial: 15456084
Drug: Reverset (RVT)
RxNorm normalized name: edrophonium chloride Injectable Solution [Reversol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reverset (RVT) 10-200 mg
Trial: 10968096
Drug: Droperidol 0.625
RxNorm normalized name: droPERidol 0.625 mg/mL intravenous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Droperidol 0.625 mg and Metoclopramide 10 mg (Group II)
Trial: 10968096
Drug: Droperidol 0.625
RxNorm normalized name: droPERidol 0.625 mg/mL intravenous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Droperidol 0.625 mg (Group I)
Trial: 8440364
Drug: deferred therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: deferred therapy where MP was started at the time of disease progression
Trial: 3911367
Drug: Cimetidine 800
RxNorm normalized name: cimetidine 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 800 mg at night
Trial: 30244144
Drug: Subthreshold nanosecond
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subthreshold nanosecond laser (SNL) treatment
Trial: 31373520
Drug: Guided internet-delivered
RxNorm normalized name: DELIVER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guided internet-delivered cognitive behavior therapy (ICBT) for panic disorder
Trial: 25888515
Drug: Cont (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cont (no drugs)
Trial: 11250999
Drug: High-dose alkylating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose alkylating agents (HDC) with autologous cellular support after doxorubicin-based therapy (AFM)
Trial: 9385483
Drug: mibefradil 100
RxNorm normalized name: mibefradil 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mibefradil 100 mg
Trial: 9385483
Drug: diltiazem CD
RxNorm normalized name: Diltiazem Hydrochloride 300 MG Oral Capsule, Extended Release, 24 HR [DILTIAZEM CD]
DrugBank: Diltiazem (DB00343)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: diltiazem CD 360 mg
Trial: 8487048
Drug: Standard regimen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard regimen (S) - six injections of triple intrathecal chemotherapy (TIC) consisting of methotrexate (MTX), hydrocortisone (HC), and cytarabine (ara‐C) during intensification and at every‐8‐week intervals for 17 additional doses.
Trial: 2403586
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (2 1-g capsules with each meal for 12 weeks)
Trial: 1093506
Drug: Haloperidol (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol (0.25 mg/kg)
Trial: 775883
Drug: Haloperidol (0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol (0.05 mg/kg)
Trial: 2649118
Drug: Haloperidol (high
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol (high dose)
Trial: 8329904
Drug: 50 μg
RxNorm normalized name: penicillin G 50 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 μg fentanyl added to 20 ml of 0.5% bupivacaine
Trial: 8329904
Drug: 75 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 μg fentanyl added to 20 ml of 0.5% bupivacaine
Trial: 8329904
Drug: 100 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 μg fentanyl added to 20 ml of 0.5% bupivacaine
Trial: 26338457
Drug: GnRHAG +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GnRHAG + E2 (0.075 mg/d)
Trial: 18429773
Drug: Olive oil
RxNorm normalized name: Olive Oil
DrugBank: Olive oil (DB09567)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olive oil cream (70% lanolin, 30% olive oil)
Trial: 18429773
Drug: Water-in-oil emollient
RxNorm normalized name: WATER IN OIL OINTMENT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Water-in-oil emollient cream (Bepanthen)
Trial: 1591948
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no specific treatment mentioned)
Trial: 10319057
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate (FP) 2 mg daily
Trial: 4028617
Drug: Bacampicillin 400
RxNorm normalized name: bacampicillin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bacampicillin 400 mg
Trial: 4028617
Drug: Bacampicillin 800
RxNorm normalized name: bacampicillin 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bacampicillin 800 mg
Trial: 322607
Drug: Ampicillin 500
RxNorm normalized name: ampicillin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ampicillin 500 mg
Trial: 389824
Drug: Bacampicillin (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bacampicillin (all doses)
Trial: 30012675
Drug: ATG (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ATG (2.5 mg/kg) alone
Trial: 25201708
Drug: 4 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 g/d carnosine for 14 days
Trial: 9842837
Drug: Domperidone 20
RxNorm normalized name: Domperidone
DrugBank: Domperidone (DB01184)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Domperidone 20 mg
Trial: 8846803
Drug: Nifedipine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (10 mg q.i.d.)
Trial: 8846803
Drug: Diltiazem (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem (mean 329 mg per day)
Trial: 8846803
Drug: Diltiazem (180
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem (180 mg per day)
Trial: 8846803
Drug: High-dose verapamil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose verapamil
Trial: 8846803
Drug: Calcium antagonists
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium antagonists (combined analysis)
Trial: 25290743
Drug: Acceptance and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acceptance and Commitment Therapy (ACT) with music during CWR exercise tests
Trial: 24089511
Drug: GLP‐1 (0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GLP‐1 (0.8 pmol/kg ⋅ min) continuous 24‐h infusion (prolonged)
Trial: 24089511
Drug: GLP‐1 (0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GLP‐1 (0.8 pmol/kg ⋅ min) two 4.5‐h infusions separated by 20 h (intermittent)
Trial: 24089511
Drug: GLP‐1 (0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GLP‐1 (0.8 pmol/kg ⋅ min) 4.5‐h infusion (acute)
Trial: 21757667
Drug: Intravenous saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous saline (placebo)
Trial: 9665112
Drug: Thrice-yearly deworming
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrice-yearly deworming with 500 mg mebendazole
Trial: 24464531
Drug: Alprazolam (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alprazolam (0.5 mg)
Trial: 1927238
Drug: Lorazepam (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorazepam (2.5 mg) with warning signal
Trial: 6749348
Drug: Chlorthalidone 50
RxNorm normalized name: chlorthalidone 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorthalidone 50 mg once daily
Trial: 6749348
Drug: Chlorothiazide 500
RxNorm normalized name: chlorothiazide 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorothiazide 500 mg twice daily
Trial: 6749348
Drug: Chlorothiazide 500
RxNorm normalized name: chlorothiazide 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorothiazide 500 mg once daily
Trial: 6749348
Drug: Chlorothiazide 1000
RxNorm normalized name: Chlorothiazide
DrugBank: Chlorothiazide (DB00880)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chlorothiazide 1000 mg once daily
Trial: 25550296
Drug: Indirect moxibustion
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indirect moxibustion for 30 minutes daily, five sessions weekly for 4 weeks
Trial: 10554529
Drug: Higher doses
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher doses of sodium selenite
Trial: 3515950
Drug: Cefotetan (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefotetan (2 gm single dose)
Trial: 26362564
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg dextromethorphan plus 100 mg sitagliptin
Trial: 26362564
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg sitagliptin alone
Trial: 18922381
Drug: Waon therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Waon therapy
Trial: 22677305
Drug: Diclofenac-K 12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac-K 12.5 mg liquid capsules
Trial: 15956995
Drug: Patients receiving
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients receiving atypical antipsychotics
Trial: 15956995
Drug: Patients receiving
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients receiving typical antipsychotics
Trial: 7452872
Drug: No brain
RxNorm normalized name: NITRIC OXIDE 400 mg in 500 mg TOPICAL CAPSULE [Bio NO Brain Care (Helps improve Brain blood flow and body temperature, Fermented Garlic powder)]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No brain treatment (control)
Trial: 23408728
Drug: Naltrexone SR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone SR (32 mg/day) plus bupropion SR (360 mg/day)
Trial: 15102998
Drug: Standard-dose epinephrine
RxNorm normalized name: epinephrine Metered Dose Inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose epinephrine (0.01 mg/kg)
Trial: 16148823
Drug: High-dose epinephrine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose epinephrine (0.1 mg/kg)
Trial: 15102998
Drug: High-dose epinephrine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose epinephrine (0.1 mg/kg) in asphyxia cases
Trial: 15102998
Drug: Standard-dose epinephrine
RxNorm normalized name: epinephrine Metered Dose Inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose epinephrine (0.01 mg/kg) in asphyxia cases
Trial: 11452712
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg extended-release (ER) buspirone tablets
Trial: 11452712
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg immediate-release (IR) buspirone tablets
Trial: 3134359
Drug: Indomethacin (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (25 mg three times daily for six weeks)
Trial: 28219129
Drug: Propofol (3.5‐4.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (3.5‐4.0 μg/ml target controlled infusion)
Trial: 14504152
Drug: Placebo patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo patch (applied 30 min before venepuncture)
Trial: 7002524
Drug: Guanfacine (new
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guanfacine (new antihypertensive drug)
Trial: 26714385
Drug: Tolvaptan 15
RxNorm normalized name: tolvaptan 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolvaptan 15 mg daily for 12 months
Trial: 17628686
Drug: no immediate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: no immediate treatment
Trial: 11500608
Drug: lansoprazole 60
RxNorm normalized name: dexlansoprazole 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lansoprazole 60 mg once daily
Trial: 1157027
Drug: Postoperative chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative chemotherapy with VAC for patients with embryonal carcinoma of the ovary
Trial: 1157027
Drug: Chemotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy with VAC for advanced embryonal carcinoma of the ovary
Trial: 1157027
Drug: Combined irradiation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined irradiation and chemotherapy with vincristine and actinomycin-D
Trial: 31331789
Drug: Alirocumab (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alirocumab (75 mg up to 150 mg every 2 weeks [COMBO I & II] or 150 mg every 2 weeks [LONG TERM])
Trial: 23639822
Drug: Motion style
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Motion style acupuncture treatment (MSAT)
Trial: 22151475
Drug: Nonsteroidal anti‐inflammatory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonsteroidal anti‐inflammatory drug (NSAID) injection (diclofenac)
Trial: 17694218
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg of 1% ropivacaine gel (ropivacaine‐20)
Trial: 17694218
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg of EMLA cream (EMLA‐60)
Trial: 11799841
Drug: New bromazepam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New bromazepam slow-release formulation
Trial: 11799841
Drug: Conventional bromazepam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional bromazepam formulation
Trial: 9516090
Drug: Dornase alfa
RxNorm normalized name: Dornase Alfa
DrugBank: Dornase alfa (DB00003)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dornase alfa 2.5 mg daily for 2 weeks via Medic‐Aid Durable SideStream nebulizer (MMAD 2.1 microm)
Trial: 9516090
Drug: Dornase alfa
RxNorm normalized name: Dornase Alfa
DrugBank: Dornase alfa (DB00003)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dornase alfa 2.5 mg daily for 2 weeks via Hudson T Up‐draft nebulizer (MMAD 4.9 microm)
Trial: 8194024
Drug: Etoposide 25
RxNorm normalized name: Etoposide
DrugBank: Etoposide (DB00773)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Etoposide 25 mg/m2/day
Trial: 8194024
Drug: Etoposide 20
RxNorm normalized name: etoposide 20 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etoposide 20 mg/m2/day
Trial: 17883519
Drug: Zolmitriptan orally
RxNorm normalized name: Zolmitriptan Orally Disintegrating Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zolmitriptan orally disintegrating tablets (ODT) 2.5 mg
Trial: 12412823
Drug: Zolmitriptan nasal
RxNorm normalized name: Zolmitriptan Nasal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zolmitriptan nasal spray 5 mg
Trial: 17883519
Drug: Conventional zolmitriptan
RxNorm normalized name: Zolmitriptan
DrugBank: Zolmitriptan (DB00315)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional zolmitriptan tablets 2.5 mg
Trial: 23320402
Drug: Transdermal fentanyl
RxNorm normalized name: fentanyl Transdermal System
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Transdermal fentanyl (TDF)